David Loasby
- SEC CIK
- 0001775863
- Latest filing
- Feb 13, 2026
GSK holding history
GSK plc in every 13F filed by David Loasby, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GSK overviewAll 13F holders of GSKFull Q4 2025 holdings
- Shares (Q4 2025)
- 24,429
- Value
- $1.23M
- % of portfolio
- 0.1%
- Quarters held
- 12
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 24,429 | $1.23M | 0.1% | +9,262+61.1% | Added | Holders |
| Q3 2025 | 15,167 | $659.8K | 0.1% | +70+0.5% | Added | Holders |
| Q2 2025 | 15,097 | $567.0K | <0.1% | +813+5.7% | Added | Holders |
| Q1 2025 | 14,284 | $479.9K | <0.1% | +2,607+22.3% | Added | Holders |
| Q4 2024 | 11,677 | $386.4K | <0.1% | −1,538−11.6% | Reduced | Holders |
| Q3 2024 | 13,215 | $507.1K | <0.1% | +430+3.4% | Added | Holders |
| Q2 2024 | 12,785 | $493.0K | <0.1% | +795+6.6% | Added | Holders |
| Q1 2024 | 11,990 | $490.1K | <0.1% | −124−1.0% | Reduced | Holders |
| Q4 2023 | 12,114 | $475.0K | 0.1% | −1,920−13.7% | Reduced | Holders |
| Q3 2023 | 14,034 | $506.3K | 0.1% | +4,537+47.8% | Added | Holders |
| Q2 2023 | 9,497 | $323.7K | <0.1% | +1,644+20.9% | Added | Holders |
| Q1 2023 | 7,853 | $298.4K | <0.1% | +7,853 | New | Holders |